Accexible’s vocal biomedical platform enables remote, digital cost effective speech analysis for early diagnosis and monitoring of mild cognitive impairment and dementia.
Intellectual property protection for Accexible’s platform
The platform has been validated through clinical studies in Europe.
Our 60 second test has a detection accuracy of > 91%.